血红蛋白与红细胞分布宽度比值与慢性危重症患者短期死亡率的关联:一项回顾性队列研究
本研究基于MIMIC-IV数据库1541例慢性危重症(CCI)患者进行回顾性分析,采用Kaplan-Meier生存曲线和多变量Cox回归评估血红蛋白与红细胞分布宽度比值(HRR)与28天及90天全因死亡率的关系。结果显示HRR与28天(HR=0.74,95%CI 0.68-0.81,P<0.001)和90天(HR=0.74,95%CI 0.69-0.8,P<0.001)全因死亡率呈显著负相关;校正年龄、性别及其他临床变量后,HRR仍与较低死亡风险独立相关(28天:HR=0.84,95%CI 0.77-0.92,P<0.001;90天:HR=0.82,95%CI 0.76-0.89,P<0.001)。按HRR四分位分组,与Q1相比,Q2、Q3、Q4的28天死亡风险分别降低34%、27%、43%,90天死亡风险分别降低32%、38%、49%。结论认为HRR是CCI患者短期全因死亡的独立预测因子,可能作为临床风险分层和个体化治疗的有用工具。
要点
- 在1541例CCI患者中,HRR与28天全因死亡率独立负相关(校正后HR=0.84,95%CI 0.77-0.92,P<0.001)。
- HRR与90天全因死亡率同样独立负相关(校正后HR=0.82,95%CI 0.76-0.89,P<0.001)。
- 按HRR四分位分组,与Q1相比,Q2、Q3、Q4的28天死亡风险分别降低34%、27%、43%。
- 与Q1相比,Q2、Q3、Q4的90天死亡风险分别降低32%、38%、49%。
- 作者认为HRR可能作为CCI患者临床风险分层和个体化治疗的工具。
适用人群与场景
- 重症监护病房(ICU)中的慢性危重症(CCI)患者,数据来自Medical Information Mart for Intensive Care IV数据库,共1541例。
研究设计与关键结果
- 研究类型:回顾性队列研究,样本量1541例CCI患者,数据来源为Medical Information Mart for Intensive Care IV数据库。
- 主要终点:HRR与28天全因死亡率显著负相关(HR=0.74,95%CI 0.68-0.81,P<0.001);校正年龄、性别及其他临床变量后仍显著(HR=0.84,95%CI 0.77-0.92,P<0.001)。
- 主要终点:HRR与90天全因死亡率显著负相关(HR=0.74,95%CI 0.69-0.8,P<0.001);校正后仍显著(HR=0.82,95%CI 0.76-0.89,P<0.001)。
- HRR四分位分析:与Q1相比,Q2、Q3、Q4的28天死亡风险分别降低34%、27%、43%;90天死亡风险分别降低32%、38%、49%。
- Kaplan-Meier生存曲线用于评估不同HRR四分位组患者的生存概率。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为HRR可能作为CCI患者临床风险分层和个体化治疗的有用工具,并为HRR作为预后评估工具的潜在价值提供了证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to investigate the association between the hemoglobin-to-red cell distribution width ratio (HRR) and 28-day and 90-day all-cause mortality in patients with chronic critical illness (CCI) in the intensive care unit.
METHODS: We conducted a retrospective analysis of data from 1,541 CCI patients in the Medical Information Mart for Intensive Care IV database. Kaplan-Meier survival curves were used to assess the survival probabilities of patients across different HRR quartiles, and a multivariable Cox regression model was applied to adjust for potential confounding factors and evaluate the relationship between HRR and the risk of mortality.
RESULTS: The analysis revealed a significant inverse association between HRR and both 28-day (hazard ratio [HR] = 0.74, 95% confidence interval [CI] 0.68-0.81, P < 0.001) and 90-day (HR = 0.74, 95% CI 0.69-0.8, P < 0.001) all-cause mortality. In the multivariable Cox regression model, HRR remained significantly associated with a lower risk of mortality even after adjusting for age, gender, and other clinical variables (28-day: HR = 0.84, 95% CI 0.77-0.92, P < 0.001; 90-day: HR = 0.82, 95% CI 0.76-0.89, P < 0.001). HRR quartile analysis showed that compared with Q1, the 28-day mortality risk was reduced by 34%, 27%, and 43% for Q2, Q3, and Q4, respectively, and the 90-day mortality risk was reduced by 32%, 38%, and 49% for Q2, Q3, and Q4, respectively.
CONCLUSIONS: HRR is an independent predictor of short-term all-cause mortality in CCI patients and may serve as a useful tool for clinical risk stratification and personalized treatment. This finding provides evidence for the potential value of HRR as a prognostic assessment tool and may have significant implications for clinical decision-making and patient management.
参考来源
- Wang C, Wang C, Luo Z, et al. Association of Hemoglobin-to-Red Cell Distribution Width Ratio with Short-Term Mortality in Chronic Critically Ill Patients: A Retrospective Cohort Study. Shock. 2025. PMID: 41427820. doi:10.1097/SHK.0000000000002757
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。